BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37759471)

  • 1. Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer.
    Sauer N; Matkowski I; Bodalska G; Murawski M; Dzięgiel P; Calik J
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin-induced protein (PIP)-characterization and role in breast cancer progression.
    Urbaniak A; Jablonska K; Podhorska-Okolow M; Ugorski M; Dziegiel P
    Am J Cancer Res; 2018; 8(11):2150-2164. PubMed ID: 30555735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP) as Functional Salivary Biomarker for Primary Sjögren's Syndrome.
    Gallo A; Martini D; Sernissi F; Giacomelli C; Pepe P; Rossi C; Riveros P; Mosca M; Alevizos I; Baldini C
    J Genet Syndr Gene Ther; 2013 Jun; 4():. PubMed ID: 24416635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast.
    Pagani A; Sapino A; Eusebi V; Bergnolo P; Bussolati G
    Virchows Arch; 1994; 425(5):459-65. PubMed ID: 7850069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of tissue- and hormone-specific regulation of the human prolactin-inducible protein/gross cystic disease fluid protein-15 gene in transgenic mice.
    Myal Y; Iwasiow B; Cosby H; Yarmill A; Blanchard A; Tsuyuki D; Fresnoza A; Duckworth ML; Shiu RP
    J Mol Endocrinol; 1998 Oct; 21(2):217-23. PubMed ID: 9801465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prolactin-inducible protein (PIP/GCDFP-15) gene: cloning, structure and regulation.
    Myal Y; Robinson DB; Iwasiow B; Tsuyuki D; Wong P; Shiu RP
    Mol Cell Endocrinol; 1991 Sep; 80(1-3):165-75. PubMed ID: 1955075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes.
    Darb-Esfahani S; von Minckwitz G; Denkert C; Ataseven B; Högel B; Mehta K; Kaltenecker G; Rüdiger T; Pfitzner B; Kittel K; Fiedler B; Baumann K; Moll R; Dietel M; Eidtmann H; Thomssen C; Loibl S
    BMC Cancer; 2014 Jul; 14():546. PubMed ID: 25070172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer.
    Naderi A; Meyer M
    Breast Cancer Res; 2012 Jul; 14(4):R111. PubMed ID: 22817771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific androgen-inhibited gene expression of a submaxillary gland protein, a rodent homolog of the human prolactin-inducible protein/GCDFP-15 gene.
    Myal Y; Iwasiow B; Yarmill A; Harrison E; Paterson JA; Shiu RP
    Endocrinology; 1994 Oct; 135(4):1605-10. PubMed ID: 7925123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin-induced protein as a potential therapy response marker of adjuvant chemotherapy in breast cancer patients.
    Jablonska K; Grzegrzolka J; Podhorska-Okolow M; Stasiolek M; Pula B; Olbromski M; Gomulkiewicz A; Piotrowska A; Rys J; Ambicka A; Ong SH; Zabel M; Dziegiel P
    Am J Cancer Res; 2016; 6(5):878-93. PubMed ID: 27293986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin Induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancer.
    Gangadharan A; Nyirenda T; Patel K; Jaimes-Delgadillo N; Coletta D; Tanaka T; Walland AC; Jameel Z; Vedantam S; Tang S; Mannion C; Lee GY; Goy A; Pecora A; Suh KS
    Breast; 2018 Jun; 39():101-109. PubMed ID: 29656222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin-inducible proteins in human breast cancer cells.
    Shiu RP; Iwasiow BM
    J Biol Chem; 1985 Sep; 260(20):11307-13. PubMed ID: 2863272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and initial characterization of the prolactin-inducible protein (PIP) null mouse: accompanying global changes in gene expression in the submandibular gland.
    Blanchard A; Nistor A; Castaneda FE; Martin D; Hicks GG; Amara F; Shiu RP; Myal Y
    Can J Physiol Pharmacol; 2009 Oct; 87(10):859-72. PubMed ID: 20052012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin-induced protein is required for cell cycle progression in breast cancer.
    Naderi A; Vanneste M
    Neoplasia; 2014 Apr; 16(4):329-42.e1-14. PubMed ID: 24862759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor.
    Carsol JL; Gingras S; Simard J
    Mol Endocrinol; 2002 Jul; 16(7):1696-710. PubMed ID: 12089361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prolactin Inducible Protein Modulates Antitumor Immune Responses and Metastasis in a Mouse Model of Triple Negative Breast Cancer.
    Edechi CA; Ikeogu NM; Akaluka GN; Terceiro LEL; Machado M; Salako ES; Barazandeh AF; Kung SKP; Uzonna JE; Myal Y
    Front Oncol; 2021; 11():639859. PubMed ID: 33777801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.
    Simard J; Dauvois S; Haagensen DE; Lévesque C; Mérand Y; Labrie F
    Endocrinology; 1990 Jun; 126(6):3223-31. PubMed ID: 2351114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antibody reactivity and CD4 binding of the mammary tumor marker protein GCDFP-15 from breast cyst and its counterparts from exocrine epithelia.
    Caputo E; Autiero M; Mani JC; Basmaciogullari S; Piatier-Tonneau D; Guardiola J
    Int J Cancer; 1998 Sep; 78(1):76-85. PubMed ID: 9724097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gross cystic disease fluid protein-15/prolactin-inducible protein as a biomarker for keratoconus disease.
    Priyadarsini S; Hjortdal J; Sarker-Nag A; Sejersen H; Asara JM; Karamichos D
    PLoS One; 2014; 9(11):e113310. PubMed ID: 25405607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesis and immunobiochemical characterization of gp17/GCDFP-15. A glycoprotein from seminal vesicles and from breast tumors, in HeLa cells and in Pichia pastoris yeast.
    Caputo E; Carratore V; Ciullo M; Tiberio C; Mani JC; Piatier-Tonneau D; Guardiola J
    Eur J Biochem; 1999 Oct; 265(2):664-70. PubMed ID: 10504398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.